You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKesson
AstraZeneca
Medtronic
Colorcon

Last Updated: January 26, 2021

DrugPatentWatch Database Preview

Patent: 8,106,158

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,106,158
Title:Compositions and methods for fusion protein separation
Abstract: The present invention relates to compositions and methods for fusion protein separation utilizing a peptide linker comprising a novel thrombin cleavage site.
Inventor(s): Kim; Sujeong (Seoul, KR), Kim; Jong-Mook (Seoul, KR), Xu; Song Shan (Beijing, CN)
Assignee: ViroMed Co., Ltd. (KR)
Application Number:12/431,687
Patent Claims:see list of patent claims

Details for Patent 8,106,158

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial ViroMed Co., Ltd. (KR) 2025-04-20 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial ViroMed Co., Ltd. (KR) 2025-04-20 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial ViroMed Co., Ltd. (KR) 2025-04-20 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial ViroMed Co., Ltd. (KR) 2025-04-20 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 8,106,158

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2006126102   Start Trial
United States of America 2006276625   Start Trial
United States of America 2008171852   Start Trial
United States of America 2010285526   Start Trial
United States of America 7585943   Start Trial
South Korea 101312339   Start Trial
South Korea 20080002845   Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Express Scripts
Merck
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.